4//SEC Filing
Watson David Hibbert 4
Accession 0001415889-25-011085
CIK 0000100591other
Filed
Apr 20, 8:00 PM ET
Accepted
Apr 21, 4:41 PM ET
Size
31.0 KB
Accession
0001415889-25-011085
Insider Transaction Report
Form 4
ARGAN INCAGX
Watson David Hibbert
DirectorPRESIDENT AND CEO
Transactions
- Award
Option to Purchase Common Stock
2025-04-16+2,000→ 13,334 totalExercise: $148.72From: 2026-04-16Exp: 2035-04-16→ Common Stock (2,000 underlying) - Exercise/Conversion
Common Stock
2025-04-16+1,856→ 52,647 total - Exercise/Conversion
Common Stock
2025-04-17+2,286→ 54,933 total - Exercise/Conversion
Common Stock
2025-04-18+1,958→ 56,891 total - Award
Earnings Per Share Performance-Based Restricted Stock Units
2025-04-16+7,500→ 25,500 totalExercise: $0.00→ Common Stock (7,500 underlying) - Exercise/Conversion
Time-Based Restricted Stock Units
2025-04-18−3,334→ 14,667 totalExercise: $0.00→ Common Stock (3,334 underlying) - Sale
Common Stock
2024-12-23$139.89/sh−500$69,945→ 0 total(indirect: By Foundation) - Exercise/Conversion
Common Stock
2025-04-18+11,745→ 68,636 total - Exercise/Conversion
Performance-Based Restricted Stock Units
2025-04-18−10,000→ 12,000 totalExercise: $0.00→ Common Stock (10,000 underlying) - Exercise/Conversion
Time-Based Restricted Stock Units
2025-04-16−3,333→ 18,001 totalExercise: $0.00→ Common Stock (3,333 underlying) - Award
Time-Based Restricted Stock Units
2025-04-16+4,000→ 22,001 totalExercise: $0.00→ Common Stock (4,000 underlying) - Award
Performance-Based Restricted Stock Units
2025-04-16+3,000→ 22,000 totalExercise: $0.00→ Common Stock (3,000 underlying) - Exercise/Conversion
Time-Based Restricted Stock Units
2025-04-17−4,000→ 18,001 totalExercise: $0.00→ Common Stock (4,000 underlying)
Footnotes (8)
- [F1]Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on April 16, 2024, 3,333 shares of Common Stock became issuable to the Reporting Person on April 16, 2025.
- [F2]Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on April 17, 2023, 4,000 shares of Common Stock became issuable to the Reporting Person on April 17, 2025.
- [F3]Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on April 18, 2022, 3,334 shares of Common Stock became issuable to the Reporting Person on April 18, 2025.
- [F4]Pursuant to three-year performance period vesting schedule of the Performance-Based Restricted Stock Units ("PRSUs") awarded to the Reporting Person on April 18, 2022, 20,000 shares of the Issuer's Common stock became issuable to the Reporting Person on April 18, 2025. The target number of shares was 10,000.
- [F5]On April 16, 2025 the Reporting Person was granted TRSUs covering 4,000 shares of common stock. The TRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 4/16/2026.
- [F6]On April 16, 2025, the Reporting Person received 10-year options to purchase 2,000 shares of the Issuer's common stock with an exercise price of $148.72 per share. The options will vest ratably over three years on each anniversary of the grant date starting on 4/16/2026.
- [F7]On April 16, 2025, the Reporting Person was granted PRSUs in the target number of 3,000 shares, the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2025 Proxy Statement. Each PRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the target number of 3,000 shares, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.
- [F8]On April 16, 2025, the Reporting Person was granted Earnings Per Share Performance-Based Restricted Stock Units ("EPSRSUs") in the target number of 7,500 shares, the vesting of which is subject to the sum of Earnings Per Share ("EPS") for fiscal years ending January 31, 2026, 2027 and 2028 compared to target compounded growth EPS amounts based on the sum of EPS for the fiscal years ended January 31, 2023, 2024 and 2025. The pay-out ratio of the target number of 7,500 shares, ranging from 0% to 200%, will depend on the degree of achievement of the EPS ranking at the end of the three-year performance period.
Documents
Issuer
ARGAN INC
CIK 0000100591
Entity typeother
Related Parties
1- filerCIK 0001482442
Filing Metadata
- Form type
- 4
- Filed
- Apr 20, 8:00 PM ET
- Accepted
- Apr 21, 4:41 PM ET
- Size
- 31.0 KB